Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the complianz-gdpr domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/www/www.genoskin.com/ftp.cluster006.ovh.net/www/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wp-extended-search domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/www/www.genoskin.com/ftp.cluster006.ovh.net/www/wp-includes/functions.php on line 6114
Blog Archives - Page 3 of 6 - Genoskin

Blog

29
Feb

The Silent Crisis in Biomedical Research: Beyond Macaques

The Silent Crisis in Biomedical Research: Beyond MacaquesFinding an alternative to non-human primates to evaluate human therapeutics In a compelling narrative echoed by Le Monde, the biomedical sector faces a silent crisis, highlighting the geopolitical intricacies and ethical quandaries of scientific research. At its core, the dwindling supply of non-human primates (NHPs), particularly macaques, essential for testing medical treatments, has
Read more
29
Feb

Immunogenicity series: Wanted Immunogenicity for Vaccine Development

Immunogenicity SeriesPart 2 - Wanted Immunogenicity for Vaccine DevelopmentImmunogenicity is a key concept in vaccine development,referring to the ability of a vaccine to stimulate an immune response in the recipient. It is a desirable and critical characteristic because the effectiveness of a vaccine is directly linked to its ability to induce a robust and protective immune response. Vaccine Development: Global
Read more
15
Feb

Genoskin at SOT 63rd Annual Meeting and ToxExpo

Genoskin at SOT 63rd Annual Meeting and ToxExpoPioneering Human Skin Models for Advanced Toxicology ResearchAs the world of toxicology convened for the Society of Toxicology 63rd Annual Meeting and ToxExpo, Genoskin was excited to announce its participation in this event, which took place from March 10-14 at the Salt Palace Convention Center in Salt Lake City. This year, Genoskin showcased
Read more
9
Feb

Understanding Local Tolerance

Understanding Local Tolerancein Drug DevelopmentIn the ever-evolving field of drug development, ensuring the safety and efficacy of new therapeutic agents is paramount. A crucial aspect of this safety evaluation is the assessment of cytotoxicity – the potential of substances to harm or destroy cells. Particularly in the realm of skin cytotoxicity, the concept of Local Tolerance, especially in the context
Read more
10
Jan

Immunogenicity series: Defining immunogenicity

Immunogenicity SeriesPart 1 - Defining immunogenicity Immunogenicity plays a pivotal role in drug and vaccine development and is essential for optimizing therapeutic efficacy and safetyby understanding the immune system's response to the compounds being tested. This is particularly crucial in the era of biologics and personalized medicine, where the fine balance between therapeutic benefit and immune reactivity is critical. Whether
Read more
23
Nov

Discover how VaxSkin® can transform your vaccine development

Research HighlightOur latest publication is now available! Discover how VaxSkin® can transform your vaccine development.The landscape of vaccine research is undergoing an important transformation, thanks to the breakthroughs in mRNA vaccine technology.This innovation has catalyzed the development of vaccines that are not only highly effective but also rapidly deployable at a large scale. With the increasing number of research institutions,
Read more